Mifepristone (RU-486)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Mifepristone (RU-486), covering 2009-12-09 to 2016-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas [Phase 2]